113136-80-4

Basic information

• Product Name: Cyclopropanecarboxylic acid, 1-[[(4-bromophenyl)amino]carbonyl]-
• CAS NO: 113136-80-4
• Molecular Formula: C11H10BrNO3
• Molecular Weight: 284.109
• Mol File: 113136-80-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Cyclopropanecarboxylic acid, 1-[[(4-bromophenyl)amino]carbonyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclopropanecarboxylic acid, 1-[[(4-bromophenyl)amino]carbonyl]-(113136-80-4)
• EPA Substance Registry System: Cyclopropanecarboxylic acid, 1-[[(4-bromophenyl)amino]carbonyl]-(113136-80-4)

Safety Data

• Hazardous Substances Data: 113136-80-4(Hazardous Substances Data)

Upstream product

• 598-10-7 cyclopropane-1,1-dicarboxylic acid 
• 40258-99-9 1-(chlorocarbonyl)cyclopropane-1-carboxylic acid 
• 106-40-1 4-bromo-aniline 

Downstream Products

• 1584219-82-8 N-(3-fluoro-4-((2-((3-((methylsulfonyl)methyl)phenyl)amino)pyrimidin-4-yl)oxy)phenyl)-N'-(4-bromophenyl)cyclopropane-1,1-dicarboxamide 
• 1584219-77-1 N-(4-((2-((3-((methylsulfonyl)methyl)phenyl)amino)pyrimidin-4-yl)oxy)phenyl)-N'-(4-bromophenyl)cyclopropane-1,1-dicarboxamide 

Relevant articles and documents

NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS

The present disclosure compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the TEAD transcription factor, and are useful in the treatment of diseases related to the activity of TEAD transcription factor including, e.g., cancer and other diseases.

Discovery of a highly potent, selective and novel CDK9 inhibitor as an anticancer drug candidate

A series of novel hybrid structure derivatives, containing both LEE011 and Cabozantinib pharmacophore, were designed, synthesized and evaluated. Surprisingly, a compound 4d was discovered that highly exhibited effective and selective activity of CDK9 inhi